Clinical Trials Sponsored by PharmAthene UK Limited

Total 122 results

PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase II Study of Range and Schedule of rPA Doses

Prevention of Bacillus Anthracis (Anthrax) Infection

United Kingdom
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)

Plague

United States, United Kingdom
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Bacillus Anthracis (Anthrax)

United States
Vaccitech (UK) Limited

Recruiting

Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

Prostate Cancer

United States
LumiraDx UK Limited

Suspended

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test (INFORM)

Covid19 | RSV Infection | Influenza Type B | Influenza Type A

United Kingdom
LumiraDx UK Limited

Active, not recruiting

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests (NOVEL-3)

Inflammation | Embolism and Thrombosis | Infection

United States
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
LumiraDx UK Limited

Suspended

Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites (PURSUE)

COVID-19 | SARS-CoV-2 | Influenza A | Influenza B

United States
Vaccitech (UK) Limited

Completed

Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model

Influenza

Belgium
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
LumiraDx UK Limited

Recruiting

Collection of Blood Samples for New Diagnostic Devices 2 (NOVEL-2)

Infections | Inflammation | Embolism and Thrombosis | Cardiovascular | Renal

United Kingdom
Vaccitech (UK) Limited

Recruiting

Efficacy of VTP-300 in Chronic Hepatitis B Infection

Chronic Hepatitis B

Taiwan, Hong Kong, Thailand
LumiraDx UK Limited

Recruiting

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites (INSPIRE)

Influenza, Human | Respiratory Syncytial Virus Infections

United States
LumiraDx UK Limited

Completed

A Performance Evaluation of the Lumiradx Point of Care HbA1c Device (PHADE)

Diabetes

United Kingdom
LumiraDx UK Limited

Suspended

COVID-19: A POC Test Under Research & Evaluation (CAPTURE)

COVID-19

United Kingdom
LumiraDx UK Limited

Completed

A Performance Evaluation of the LumiraDx Point of Care CRP Assay (REACT)

Infections | Inflammation | Tissue Injury

United Kingdom
LumiraDx UK Limited

Active, not recruiting

A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay (EMBOL1)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United Kingdom, Germany
LumiraDx UK Limited

Completed

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test (VKA GERMANY)

Anticoagulants and Bleeding Disorders

Germany
LumiraDx UK Limited

Completed

Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) (OPTIMAL)

Atrial Fibrillation | Thrombophilia | Deep Vein Thrombosis | Antiphospholipid Syndrome | Pulmonary Embolism | Post-Myocardial Infarction Syndrome | Artificial Heart Device User

United Kingdom
PanGenetics UK Limited

Terminated

Single Dose PG102 in Patients With Active Psoriatic Arthritis

Arthritis, Psoriatic

Serbia
LumiraDx UK Limited

Active, not recruiting

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test (ASPIRE)

Covid19

United States
LumiraDx UK Limited

Active, not recruiting

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2) (ASPIRE-2)

COVID-19

United States
LumiraDx UK Limited

Active, not recruiting

Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test (CAPTURE-2)

Covid19

United States
Vaccitech (UK) Limited

Active, not recruiting

First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV

Hepatitis B

Korea, Republic of, Taiwan, United Kingdom
Vaccitech (UK) Limited

Completed

First in Human Study of ChAdOx1-HBV

Healthy | Hepatitis B

United Kingdom
EusaPharma (UK) Limited

Terminated

Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease (SISREMCAD)

Idiopathic Multicentric Castleman's Disease

United States
Achilles Therapeutics UK Limited

Recruiting

ATL001 in Patients With Metastatic or Recurrent Melanoma

Melanoma

Spain, United Kingdom
Achilles Therapeutics UK Limited

Recruiting

ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

Advanced Non Small Cell Lung Cancer

United States, Germany, France, Spain, United Kingdom
Achilles Therapeutics UK Limited

Recruiting

Prospective Tissue Collection Research Protocol

Solid Tumor

Spain, United Kingdom, United States
Achilles Therapeutics UK Limited

Terminated

Long-Term Follow-Up Study of Patients Receiving ATL001

Melanoma | Advanced Non Small Cell Lung Cancer

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Recruiting

A Clinical Investigation to Assess the Effectiveness of Benzocaine in NRL Condoms in Healthy Adult Men Who Feel They Ejaculate Too Quickly During Vaginal Sex

Ejaculation Delayed

Germany
Skin Analytics Limited
Innovate UK

Completed

DERM NMSC Validation Study

Non-melanoma Skin Cancer

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Completed

A Clinical Investigation to Assess the Performance of Natural Rubber Latex Condoms in Couples

Control of Pregnancy | Prevention of Sexually Transmitted Infections

Thailand
Reckitt Benckiser Healthcare (UK) Limited

Completed

Ibuprofen Suspension Bioequivalence Study

Healthy Volunteer Study

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Withdrawn

A Clinical Investigation to Assess the Effectiveness of Benzocaine Condoms in Healthy Adult Men

Ejaculation Delayed
Reckitt Benckiser Healthcare (UK) Limited

Unknown

An Internet Mediated Research Study to Assess the Quality of Life of Consumers With Self-reported Fungal Nail Infection (Onychomycosis) During Treatment With Scholl Fungal Nail.

Onychomycosis of Toenail

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Terminated

Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.

Healthy Subjects
Reckitt Benckiser Healthcare (UK) Limited

Completed

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

Gastro-esophageal Reflux Disease (GERD)

China
Reckitt Benckiser Healthcare (UK) Limited

Completed

Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study

Dyspepsia | Gastroesophageal Reflux Disease

China
Reckitt Benckiser Healthcare (UK) Limited

Completed

Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action

Vaginal Dryness | Dyspareunia

Germany
Reckitt Benckiser Healthcare (UK) Limited

Completed

Clinical Investigation to Assess the Acid Neutralisation Activity of a Calcite Chewing Gum

Esophagitis | Gastro Oesophageal Reflux Disease

Ireland
Skin Analytics Limited
Innovate UK

Completed

DERM Health Economics Study

Melanoma | Non-melanoma Skin Cancer

United Kingdom
EusaPharma (UK) Limited
Syneos Health

Terminated

SILtuximab in Viral ARds (SILVAR) Study (SILVAR)

Respiratory Tract Infections | Pneumonia | Lung Diseases | Acute Respiratory Distress Syndrome | Respiratory Tract Disease

United States
Reckitt Benckiser Healthcare (UK) Limited

Completed

Ibuprofen 4% (w/v) Pivotal Bioequivalence Study

Bioequivalence of the Test Formulation
Reckitt Benckiser Healthcare (UK) Limited

Completed

Francis Biomechanics Study

Healthy Subject

Belgium
Reckitt Benckiser Healthcare (UK) Limited

Terminated

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

Gastro-esophageal Reflux Disease (GERD)

China
Reckitt Benckiser Healthcare (UK) Limited

Completed

A Clinical Investigation to Evaluate the Safety and Performance of a Treatment Kit for Ingrowing Toenail

Onychomycosis of Toenails

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Completed

Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients

Gastroesophageal Reflux Disease

China
EusaPharma (UK) Limited
United BioSource, LLC

Recruiting

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

Neuroblastoma

France, Germany, United Kingdom, Italy, Austria, Poland, Spain
Clinuvel (UK) Ltd.

Completed

Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)

Variegate Porphyria

Netherlands

Clinical Trials Sponsored by PharmAthene UK Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations